EP Patent

EP0654029A1 — 3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists

Assigned to Pfizer Inc · Expires 1995-05-24 · 31y expired

What this patent protects

The present invention relates to derivatives of formula (I). These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.

USPTO Abstract

The present invention relates to derivatives of formula (I). These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.

Drugs covered by this patent

Patent Metadata

Patent number: EP0654029A1
Jurisdiction: EP
Classification: —
Expires: 1995-05-24
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.